HIV infection and multidrug-resistant tuberculosis: the perfect storm (Q36877246)

16 August 2017

1 reference

title

HIV infection and multidrug-resistant tuberculosis: the perfect storm (English)

1 reference

multidrug-resistant tuberculosis

16 August 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

Charles D Wells

1

1 reference

16 August 2017

J Peter Cegielski

2

1 reference

16 August 2017

Lisa J Nelson

3

1 reference

16 August 2017

Kayla F Laserson

4

1 reference

16 August 2017

Timothy H Holtz

5

1 reference

16 August 2017

Alyssa Finlay

6

1 reference

16 August 2017

Kenneth G Castro

7

1 reference

16 August 2017

Karin Weyer

8

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Journal of Infectious Diseases

16 August 2017

1 reference

16 August 2017

196 Suppl 1

1 reference

16 August 2017

S86-107

1 reference

Global incidence of multidrug-resistant tuberculosis

16 August 2017

1 reference

Resource implications of patients with multidrug resistant tuberculosis

21 January 2018

1 reference

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

21 January 2018

1 reference

XDR tuberculosis: an indicator of public-health negligence

21 January 2018

1 reference

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

21 January 2018

1 reference

Does tuberculosis increase HIV load?

21 January 2018

1 reference

An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group

21 January 2018

1 reference

Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia

21 January 2018

1 reference

Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.

21 January 2018

1 reference

Sensitivity to anti-tuberculosis drugs in HIV-positive and -negative patients in Addis Ababa.

21 January 2018

1 reference

Rifampin-monoresistant tuberculosis in New York City, 1993-1994.

21 January 2018

1 reference

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

21 January 2018

1 reference

Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana

21 January 2018

1 reference

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease

21 January 2018

1 reference

Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002.

21 January 2018

1 reference

Implications of the growing HIV-1 epidemic for tuberculosis control in Russia

21 January 2018

1 reference

Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran

21 January 2018

1 reference

Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

21 January 2018

1 reference

Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy

21 January 2018

1 reference

Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002.

21 January 2018

1 reference

Epidemic of tuberculosis in the former Soviet Union: social and biological reasons

21 January 2018

1 reference

The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe

21 January 2018

1 reference

Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia

21 January 2018

1 reference

The 'bear trap': the colliding epidemics of tuberculosis and HIV in Russia

21 January 2018

1 reference

Sample survey of drug-resistant tuberculosis in Henan, China, 1996.

21 January 2018

1 reference

Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS.

21 January 2018

1 reference

Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china

21 January 2018

1 reference

Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention

21 January 2018

1 reference

The impact of HIV/AIDS on the control of tuberculosis in India

21 January 2018

1 reference

Antituberculosis drug resistance in the south of Vietnam: prevalence and trends

21 January 2018

1 reference

Global overview of injecting drug use and HIV infection among injecting drug users.

21 January 2018

1 reference

Assessing the magnitude of the HIV/AIDS epidemic in Burma

21 January 2018

1 reference

PEPFAR and HIV prevention in Africa

21 January 2018

1 reference

The two sides of PEPFAR in Uganda

21 January 2018

1 reference

An examination of the Global Fund at 5 years

21 January 2018

1 reference

Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin

21 January 2018

1 reference

Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.

21 January 2018

1 reference

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

21 January 2018

1 reference

Tuberculosis in a prison population in Malawi

21 January 2018

1 reference

Tuberculosis control and molecular epidemiology in a South African gold-mining community

21 January 2018

1 reference

HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV.

21 January 2018

1 reference

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations

21 January 2018

1 reference

Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana

21 January 2018

1 reference

International standards for tuberculosis care

21 January 2018

1 reference

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan

21 January 2018

1 reference

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

21 January 2018

1 reference

Patients with drug-resistant tuberculosis who were treated with standardized short-course chemotherapy.

21 January 2018

1 reference

Increasing transparency in partnerships for health--introducing the Green Light Committee

21 January 2018

1 reference

Tuberculosis drug development pipeline: progress and hope.

21 January 2018

1 reference

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

21 January 2018

1 reference

Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis

21 January 2018

1 reference

Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.

21 January 2018

1 reference

The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa

21 January 2018

1 reference

Factors Associated with the Development of Opportunistic Infections in HIV‐1–Infected Adults with High CD4+Cell Counts: A EuroSIDA Study

21 January 2018

1 reference

Multidrug-resistant tuberculosis at an HIV testing center in Haiti

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/518665

1 reference

16 August 2017

1 reference